NEALY v. AUROBINDO PHARMA LTD. et al
| HUNTER NEALY |
| JOHN DOE, TEVA PHARMACEUTICALS USA, INC., AUROBINDO PHARMA USA, INC., SOLCO HEALTHCARE U.S., LLC, ACTAVIS LLC, AUROBINDO PHARMA LTD., CARDINAL HEALTH, INC., MYLAN N.V., ACTAVIS PHARMA, INC., MYLAN PHARMACEUTICALS INC., TORRENT PHARMACEUTICALS, LTD., TORRENT PHARMA, INC, HETERO DRUGS, LTD., MYLAN LABORATORIES LTD., HETERO USA, INC., CAMBER PHARMACEUTICALS, INC., PRINSTON PHARMACEUTICAL INC., ARROW PHARM (MALTA) LTD., AUROLIFE PHARMA, LLC, HETERO LABS, LTD., TEVA PHARMACEUTICAL INDUSTRIES LTD., HUAHAI U.S., INC. and ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. |
| VALSARTAN N-NITROSODIMETHYLAMINE (NDMA) PRODUCTS LIABILITY LITIGATION |
| 1:2019cv19609 |
| October 31, 2019 |
| US District Court for the District of New Jersey |
| Robert B Kugler |
| Joel Schneider |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1332 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on October 31, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 3 SUMMONS ISSUED as to ACTAVIS LLC, ACTAVIS PHARMA, INC., ARROW PHARM (MALTA) LTD., AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC., AUROLIFE PHARMA, LLC, CAMBER PHARMACEUTICALS, INC., CARDINAL HEALTH, INC., JOHN DOE, HETERO DRUGS, LTD., HETERO LABS, LTD., HETERO USA, INC., HUAHAI U.S., INC., MYLAN LABORATORIES LTD., MYLAN N.V., MYLAN PHARMACEUTICALS INC., PRINSTON PHARMACEUTICAL INC., SOLCO HEALTHCARE U.S., LLC, TEVA PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC., TORRENT PHARMA, INC, TORRENT PHARMACEUTICALS, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (ssp, ) |
| Filing 2 Corporate Disclosure Statement by HUNTER NEALY. (LANE, JOSEPH) |
| Filing 1 COMPLAINT against ACTAVIS LLC, ACTAVIS PHARMA, INC., ARROW PHARM (MALTA) LTD., AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC., AUROLIFE PHARMA, LLC, CAMBER PHARMACEUTICALS, INC., CARDINAL HEALTH, INC., JOHN DOE, HETERO DRUGS, LTD., HETERO LABS, LTD., HETERO USA, INC., HUAHAI U.S., INC., MYLAN LABORATORIES LTD., MYLAN N.V., MYLAN PHARMACEUTICALS INC., PRINSTON PHARMACEUTICAL INC., SOLCO HEALTHCARE U.S., LLC, TEVA PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC., TORRENT PHARMA, INC, TORRENT PHARMACEUTICALS, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. ( Filing and Admin fee $ 400 receipt number 0312-10075783) with JURY DEMAND, filed by HUNTER NEALY. (Attachments: #1 Civil Cover Sheet)(LANE, JOSEPH) |
| Member Case Direct File on 10/31/2019, for MDL 2875 VALSARTAN N-NITROSODIMETHYLAMINE (NDMA) PRODUCTS LIABILITY LITIGATION. (ssp, ) |
| For all Case Management Orders #click here (ssp, ) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
